| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-13 |
4 |
OE |
$17.65 |
$433,166 |
D/D |
24,542 |
1,051,728 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-13 |
4 |
AS |
$161.08 |
$3,988,594 |
D/D |
(24,542) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-14 |
4 |
OE |
$17.65 |
$617,750 |
D/D |
35,000 |
1,062,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-14 |
4 |
AS |
$165.44 |
$5,807,366 |
D/D |
(35,000) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-15 |
4 |
AS |
$170.06 |
$5,952,100 |
D/D |
(35,000) |
1,027,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-15 |
4 |
OE |
$17.65 |
$617,750 |
D/D |
35,000 |
1,062,186 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-08-27 |
4 |
AS |
$169.17 |
$1,000,133 |
D/D |
(5,912) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-04 |
4 |
AS |
$165.26 |
$14,321,355 |
D/D |
(85,668) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-04 |
4 |
OE |
$17.98 |
$1,540,311 |
D/D |
85,668 |
1,106,942 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-05 |
4 |
OE |
$17.98 |
$1,634,724 |
D/D |
90,919 |
1,112,193 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-05 |
4 |
AS |
$161.91 |
$14,876,354 |
D/D |
(90,919) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-08 |
4 |
OE |
$17.98 |
$381,428 |
D/D |
21,214 |
1,042,488 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-08 |
4 |
AS |
$165.11 |
$3,502,644 |
D/D |
(21,214) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-10 |
4 |
AS |
$165.38 |
$2,017,471 |
D/D |
(12,199) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-10 |
4 |
A |
$17.98 |
$219,338 |
D/D |
12,199 |
1,033,473 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-16 |
4 |
OE |
$17.65 |
$565,630 |
D/D |
32,047 |
1,053,321 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-16 |
4 |
AS |
$159.87 |
$5,136,005 |
D/D |
(32,047) |
1,021,274 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-18 |
4 |
AS |
$161.45 |
$2,000,043 |
D/D |
(12,388) |
1,008,886 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-09-26 |
4 |
AS |
$164.83 |
$9,906,901 |
D/D |
(60,000) |
948,886 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-11-20 |
4 |
AS |
$191.96 |
$1,000,112 |
D/D |
(5,210) |
943,676 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-05 |
4 |
OE |
$17.98 |
$1,019,844 |
D/D |
56,721 |
1,000,397 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-05 |
4 |
AS |
$196.25 |
$11,181,101 |
D/D |
(56,721) |
943,676 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-08 |
4 |
OE |
$17.98 |
$1,307,156 |
D/D |
59,934 |
1,003,610 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-08 |
4 |
AS |
$196.73 |
$11,919,423 |
D/D |
(59,934) |
943,676 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2014-12-09 |
4 |
AS |
$199.94 |
$3,332,000 |
D/D |
(16,665) |
943,676 |
0 |
- |
|
283 Records found
|
|
Page 9 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
